Edwards Lifesciences Corporation Deferred Federal Income Tax Expense (Benefit)
Edwards Lifesciences Corporation (EW) reported Deferred Federal Income Tax Expense (Benefit) of -$16.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-02-25
- Edwards Lifesciences Corporation deferred federal income tax expense (benefit) for fiscal 2025 was -$16.60M.
- Edwards Lifesciences Corporation deferred federal income tax expense (benefit) for fiscal 2024 was -$117.80M.
- Edwards Lifesciences Corporation deferred federal income tax expense (benefit) for fiscal 2023 was -$165.70M.
- Edwards Lifesciences Corporation deferred federal income tax expense (benefit) for fiscal 2022 was -$197.80M.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$16.60M 10-K · filed 2026-02-25 | |
| 2024-12-31 | -$117.80M 10-K · filed 2026-02-25 | |
| 2023-12-31 | -$165.70M 10-K · filed 2026-02-25 | -$187.50M 10-K · filed 2024-02-12 |
| 2022-12-31 | -$197.80M 10-K · filed 2025-02-28 | -$187.70M 10-K · filed 2023-02-13 |
| 2021-12-31 | -$9.40M 10-K · filed 2024-02-12 | |
| 2020-12-31 | $11.00M 10-K · filed 2023-02-13 | |
| 2019-12-31 | $28.30M 10-K · filed 2022-02-14 | |
| 2018-12-31 | -$16.10M 10-K · filed 2021-02-12 | |
| 2017-12-31 | $39.30M 10-K · filed 2020-02-14 | |
| 2016-12-31 | -$19.60M 10-K · filed 2019-02-15 | |
| 2015-12-31 | -$12.50M 10-K · filed 2018-02-16 | |
| 2014-12-31 | -$46.40M 10-K · filed 2017-02-17 | |
| 2013-12-31 | $39.80M 10-K · filed 2016-02-19 | $41.20M 10-K · filed 2014-02-28 |
| 2012-12-31 | -$24.90M 10-K · filed 2015-02-20 | -$23.80M 10-K · filed 2013-02-28 |
| 2011-12-31 | -$6.40M 10-K · filed 2014-02-28 | |
| 2010-12-31 | -$1.80M 10-K · filed 2013-02-28 | |
| 2009-12-31 | -$7.70M 10-K · filed 2012-02-27 | |
| 2008-12-31 | -$21.30M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |